FDA 483 - Kedrion Biopharma Inc. - March 27, 2024
Discuss this record with AI
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.
Kedrion Biopharma, Inc. in Melville, NY, was inspected from March 20-27, 2024, and received a Form 483 with two observations. The inspection revealed issues with ineffective cleaning procedures for critical manufacturing equipment, leading to multiple temperature excursions in the fractionation department. Additionally, the firm failed to document deviations from batch production and control records, with numerous temperature excursions identified only after batch completion.
ID · f9576627-ce90-4755-8c13-1b00e51568c4